What people are saying - Write a review
We haven't found any reviews in the usual places.
Regulatory Implications of New Risk Assessment Methodologies
FDAs Human Resources
9 other sections not shown
adverse drug reaction agency agency's Alternative Futures Alzheimer's disease amylin animal testing approval process areas biotechnology Center changes clinical trials concern Congress consumer groups consumer protection continue cooperation cosmeceuticals cosmetics countries create data bases decade decisions Delaney Clause demand Director disease Drug Administration drug approval drug development Drug Law Institute's economic effect efforts epidemiological Evaluation expert systems experts FDA and industry FDA-industry relations FDA-regulated FDCA federal Federal Food Food and Drug food safety global important improve increased increasingly innovation Institute for Alternative interest issues legislation medical devices medicine ment monitoring organizations patients Ph.D pharmaceutical companies pharmaceutical industry pharmacists physicians potential pressure problems professionals programs public health regulation requirements responsibility risk assessment risk communication role safety and efficacy scenarios scientific seafood standards studies sumer supra note testing tion trade trends U.S. companies Vice President worldwide